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Objective: The aim of the study was to identify risk factors of early and late death after surgical repair of post-
infarction ventricular septal rupture.
Methods: During a 25-year period, fromMay 1981 to August 2006, 102 patients underwent repair of postinfarc-
tion ventricular septal rupture. Data were collected on clinical, angiographic, and echocardiographic findings; op-
erative procedures; early morbidity; and survival time. Univariable and multivariable analyses were performed to
identify risk factors of 30-day mortality and total mortality.
Results: Thirty-day mortality was 33% altogether and decreased from 45% in the first half to 21% in the second
half of the period (P ¼ .01). Follow-up was a mean of 5.2  6.2 years and a median of 2.9 years (range, 0–26.3
years). Five- and 10-year cumulative survival was 50% and 32%, respectively. Shock at surgical intervention and
incomplete coronary revascularization were strong and independent risk factors of both 30-day mortality and poor
long-term survival.
Conclusions: Early outcome after repair of ventricular septal rupture improved significantly during time, with
30-day mortality being 21% in the last decade. Five- and 10-year cumulative survival was 50% and 32%, re-
spectively. Shock at surgical intervention and incomplete coronary revascularization were strong and independent
predictors of poor early and late survival.
Acquired Cardiovascular Disease Lundblad et alVentricular septal rupture (VSR) is a fatal complication after
acute myocardial infarction (AMI) and represents a major
surgical challenge. Thrombolytic therapy and acute percuta-
neous coronary intervention (PCI) have led to a 5- to 10-fold
reduction in the incidence of VSR,1-4 but the operative risk
remains high. Because of advanced age, heart transplanta-
tion and assist devices as a bridge to transplantation are sel-
dom proposed. Although prognosis is extremely poor in
medically treated patients,1,5,6 it is important to identify pa-
tients with excessive risk in whom surgical intervention can
be avoided. Several predictors of poor outcome have been
identified, including large AMI, preoperative shock, right
ventricular infarction, posterior VSR, and large left-to-right
shunt. In this single-center, retrospective study of 102 con-
secutive patients undergoing VSR repair, we describe pre-
dictors of 30-day mortality and long-term survival.
MATERIALS AND METHODS
This retrospective study was approved by the institutional review board.
Patients
During a 25-year period, from May 1981 to August 2006, 106 consec-
utive patients from the south of Norway were referred to our hospital
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vention, and therefore 102 patients underwent VSR repair and were
included in the study for follow-up. The preoperative cardiologic assess-
ment was done in our institution and included 2-dimensional Doppler echo-
cardiographic analysis and selective coronary angiographic analysis for all
patients. Details of revascularization were collected from the operative re-
cords and correlated to the angiograms, and each patient was categorized
into ‘‘yes’’ or ‘‘no’’ categories for the 2 variables of (1) complete global
coronary revascularization and (2) revascularization of the culprit artery
(infarct-related artery). Preoperative and operative risk factors of 30-day
mortality are summarized in Table 1. There were 76 men and 26 women
with a mean age of 67  8 years. Ninety patients had not experienced
AMI previously, and 12 patients had a history of 1 previous AMI. Throm-
bolysis was performed in 19 cases, and acute PCI was performed in 5 cases.
Time from AMI to diagnosis of VSR was a median of 5 days and did not
change throughout the study period. Time from VSR to surgical interven-
tion decreased from a median of 3 days in the first half to 1 day in the second
half of the study period (P ¼ .02). Shock at surgical intervention was pres-
ent in 14 patients and was strictly defined as hypoperfusion leading to acute
oliguria/anuria or acute increase in creatinine value to greater than 200
mmol/L. None of the patients had preoperative chronic renal failure that
could confound this definition. Posterior VSR was slightly more common
than anterior VSR. Shunt size was estimated in 78 cases by means of echo-
cardiographic analysis or right cardiac catheterization with oximetry, and
two thirds of them had Qp/Qs ratios of greater than 2.5. All patients had sig-
nificant coronary lesions, and for the whole cohort, the frequency of 1-, 2-,
and 3-vessel disease was approximately equal. There was a tendency toward
more 1-vessel disease in anterior VSR and more 3-vessel disease in poste-
rior VSR (P ¼ .10). The left anterior descending coronary artery was the
infarct-related artery in all patients with anterior VSR. The right coronary
artery system was the infarct-related artery in all patients with posterior
VSR, except in 1 patient with occlusion of a dominant circumflex.
Surgical Procedure
The operation was performed through a median sternotomy by using car-
diopulmonary bypass (CPB) and moderate systemic hypothermia. Ante-
grade crystalloid solution (St Thomas II) was infused for cardioplegic
arrest in all cases except 2, in which the repair was performed on the beating
heart. The VSR was approached through the infarction area of the leftgery c April 2009




AMI ¼ acute myocardial infarction
ASAT ¼ aspartate aminotransferase
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
IABP ¼ intra-aortic balloon pump
PCI ¼ percutaneous coronary intervention
VSR ¼ ventricular septal rupture
ventricle and was repaired with the traditional technique of Daggett and as-
sociates7 or the infarct-exclusion repair of David and colleagues.8 Daggett
repair (n ¼ 67) dominated in the first half and David repair (n ¼ 35) dom-
inated in the second half of the series. In Dagget repair the VSRwas patched
(Dacron or polytetrafluoroethylene patches) in all cases except 1, in which
the defect was directly closed with buttressed interrupted sutures. The ven-
triculotomy was closed with buttressed sutures or, in a few cases, resected
myocardium was replaced with prosthetic material. In David repair the in-
farcted myocardium and VSR were excluded with a large patch of bovine
pericardium and in a few cases supplemented with a second patch directly
on the VSR. The ventriculotomy was closed without infarctectomy by using
buttressed sutures. Glue was not used. No valve procedure was performed.
Coronary artery bypass grafting (CABG) was performed when significant
coronary artery disease was present and the vessel periphery was deemed
suitable for revascularization. The left internal thoracic artery and saphe-
nous vein were used for grafts. Distal anastomoses were performed on the
cardioplegic heart, and finally, proximal anastomoses were performed on
a beating heart. Sixty-six patients underwent revascularization: CABG in
61 patients, acute PCI of the culprit artery in 3 patients with 1-vessel disease,
and acute PCI of the culprit artery followed by CABG in 2 patients with 3-
vessel disease. Themean number of distal anastomoses was 1.8. The infarct-
related coronary artery was revascularized in 24 patients (left anterior de-
scending coronary artery in 11 patients and right coronary artery in 13The Journal of Thoracic and Cpatients). Of 64 patients with disease in remote coronary territories, 39
underwent complete remote revascularization, 17 had incomplete remote
revascularization, and 8 had no remote revascularization. Accordingly, 25
patients left the operating room with remote myocardium at ischemic risk
as a consequence of incomplete or no revascularization of non–infarct-re-
lated arteries. Altogether, 22 patients underwent complete coronary revas-
cularization (culprit artery plus remote arteries). An intra-aortic balloon
pump (IABP) was used in 91 patients and was started preoperatively
(>24 hours) in 21 patients and perioperatively in 70 patients. IABP was
used for a median of 4 days (range, 0–12 days) after the operation.
Study Design, Data Collection, and Statistical
Analysis
The study is a cohort analysis of 102 consecutive patients undergoing op-
erations for postinfarction VSR in our hospital during a 25-years period,
from May 1981 to August 2006. This dynamic cohort had different entry
times (date of operation), and the common closing date was July 1, 2008.
Data were collected from patient records, and survival data were entirely
based on information from the Norwegian Death Registry. Follow-up was
100% complete andwas amean of 5.2 6.2 years and amedian of 2.9 years
(range, 0–26.3 years). Continuous data are presented as the mean standard
deviation or median (range), and categorical data are frequencies or frac-
tions of patients. End points were 30-day mortality and total mortality (all
deaths including 30-day deaths).
Univariable analysis of 30-day mortality was performed with 2 3 2 ta-
bles and c2 or Fisher’s exact tests for categorical data and the 2-tailed t
test or the Mann–Whitney test for continuous data. Survival curves
were plotted according to the Kaplan–Meier method, and differences be-
tween curves were pinpointed by using the Breslow test and the log-rank
test.9
Multivariable analysis was performed for variables that demonstrated
statistical significance (P< .05) or marginal significance (P< .2) in the
univariable analysis or that were considered clinically or pathophysiolog-
ically important. Accordingly, the following variables were included in the
logistic regression analysis and the Cox model: age, sex, diabetes mellitus,TABLE 1. Patient data and risk factors of 30-day mortality
Variable All (n ¼ 102) Survivors (n ¼ 68) Nonsurvivors (n ¼ 34) P value
Age (y) 67  8 66  8 68  9 >.2
Male/female sex 76/26 49/19 27/7 >.2
BMI 24.9  2.7 25.0  2.7 24.7  2.8 >.2
Diabetes mellitus 12 8 4 >.2
Previous AMI 12 7 5 >.2
Thrombolysis/acute PCI 24 17 7 >.2
Left main stenosis 9 7 2 >.2
1/2/3-Vessel disease 38/30/34 25/18/25 13/12/9 >.2
Anterior/posterior VSR 47/55 34/34 13/21 >.2
AMI to VSR (d) 5 (1–27) 5 (1–27) 2 (1–14) .20
VSR to surgical intervention (d) 2 (0–60) 2 (0–60) 1 (0–30) .09
ASATmax (U/L)* 470  355 349  190 665  468 .01
Shunt size>2.5/<2.5y 50/28 30/24 20/4 .02
Shock at surgical intervention 14 5 9 .01
Aortic crossclamp time (min) 64  31 60  29 71  33 >.2
CPB (min) 116  45 109  40 130  53 .04
Coronary revascularization 66 47 19 .19
Complete revascularization 22 18 4 .09
Culprit revascularizationz 24 20 4 .05
Values are presented as means  SD or medians (ranges) or the number of patients or fractions of patients. BMI, Body mass index; AMI, acute myocardial infarction; PCI, per-
cutaneous coronary intervention; VSR, ventricular septal rupture; ASAT, aspartate aminotransferase; CPB, cardiopulmonary bypass. *Maximal aspartate aminotransferase after
acute myocardial infarction measured in 42 patients. yQp/Qs ratio measured in 78 patients. zRevascularization of the infarct-related artery.ardiovascular Surgery c Volume 137, Number 4 863
Acquired Cardiovascular Disease Lundblad et al
A
C
DTABLE 2. Independent risk factors of 30-day mortality by logistic regression analysis
Variable Level b SE of b OR 95% CI P value*
Global revascularization
Shock at surgical intervention Yes/no 1.57 0.66 4.81 1.31–17.60 .018
Complete revascularization Yes/no 1.72 0.70 0.18 0.05–0.70 .014
CPB time Continuous (D ¼ 10 min) 0.16 0.06 1.17 1.04–1.32 .005
Constant 2.46 0.67 0.09 <.001
Culprit artery
Shock at surgical intervention Yes/no 1.55 0.67 4.70 1.28–17.3 .02
Culprit revascularizationy Yes/no 1.81 0.69 0.16 0.04–0.63 .009
CPB time Continuous (D ¼ 10 min) 0.16 0.05 1.17 1.06–1.29 .004
Constant 2.43 0.67 0.09 <.001
b, Regression coefficient; OR, odds ratio; 95% CI, 95% confidence interval of odds ratio; CPB, cardiopulmonary bypass. *Logistic regression analysis with manual backward
elimination. yRevascularization of the infarct-related artery.left main stenosis, 3-vessel disease, location of VSR, time from AMI to
VSR, time from VSR to surgical intervention, shock at surgical interven-
tion, long CPB time, and complete coronary revascularization. Complete
coronary revascularization was assessed in 2 ways: (1) complete global re-
vascularization and (2) revascularization of the culprit artery. Because
they were internally correlated, they could not be included in the same
multivariable model. Aspartate aminotransferase (ASAT) and preoperative
shunt values were measured in 42 and 78 patients, respectively. Because
of the possibility of selection bias and loss of power, they were not in-
cluded in the multivariable model. Surgical repair method was not in-
cluded as a risk factor. This is addressed separately in an upcoming
report with a more causative approach by using the strategy of an exposed
(David) versus nonexposed (Dagget) cohort on the end-point mortality.
Logistic regression was used to identify independent risk factors of 30-
day mortality, and Cox proportional hazards regression was used to iden-
tify independent risk factors of total mortality.10 Manual backward elimi-
nation of variables was performed based on the following criteria: clinical
or pathophysiologic importance, correlation matrix between the variables,
and statistical significance of the Wald test. SPSS for Windows (version
13.0; SPSS, Inc, Chicago, Ill) and OpenEpi (version 2.2.1) were used
for statistical calculations. The reporting of results is performed in accor-
dance with the Strengthening the Reporting of Observational Studies in
Epidemiology guidelines for cohort studies.11,12
RESULTS
Early Morbidity
Reoperation for wound bleeding was performed in 14 pa-
tients, and 5 patients underwent reoperation for deep sternal
infection. The most common postoperative organ malfunc-
tions were renal and respiratory failure. Four patients with
low output required mechanical circulatory assistance be-
yond IABP to exit the operating room; 3 had univentricular
assist with centrifugal pumps (left ventricular assist, 1; right
ventricular assist, 2), and 1 had venoarterial cardiac bypass
with extracorporeal membrane oxygenation. Two of them
died early (on the operating table and at day 13, respec-
tively), and 2 were late survivors (4 and 6 years, respec-
tively). Examination for postoperative shunt was
performed by means of echocardiography or oxymetry in
76 patients within the first 30 days after surgical interven-
tion. One third of them had a residual shunt or reshunt,
and 12 patients underwent reoperation, the majority within
30 days after the primary procedure.864 The Journal of Thoracic and Cardiovascular SuThirty-day Mortality
Thirty-day mortality was 33% for the whole cohort and
decreased from 45% in the first half to 21% in the second
half of the study period (P ¼ .01). Significant risk factors
of 30-day mortality by means of univariable analysis (Table
1) were large AMI (high ASAT levels), large preoperative
shunt (Qp/Qs>2.5), shock at surgical intervention, long
CPB time, and no revascularization of the culprit artery. In-
dependent risk factors of 30-day mortality were shock at sur-
gical intervention, long CPB time, and incomplete coronary
revascularization (Table 2). Both incomplete global revascu-
larization and no revascularization of the culprit artery were
independent predictors of 30-day mortality. Anterior or pos-
terior location of the VSR did not influence early outcome.
Long-term Survival
Five- and 10-year cumulative survival for all patients was
50% and 32%, respectively (Figure 1). Significant risk fac-
tors of total mortality by means of univariable analysis were
advanced age, large preoperative shunt (Qp/Qs>2.5), shock
at surgical intervention, and long CPB time. Independent
risk factors of total mortality were advanced age, shock at
surgical intervention, long CPB time, and incomplete coro-
nary revascularization (Table 3). Both incomplete global
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FIGURE 1. Cumulative survival after repair of postinfarction ventricular
septal regurgitation (VSR) in 102 patients.rgery c April 2009
Lundblad et al Acquired Cardiovascular DiseaseTABLE 3. Independent risk factors of total mortality by means of Cox regression analysis
Variable Level b SE of b RR 95% CI P value*
Global revascularization
Age Continuous (D ¼ 10 y) 0.53 0.18 1.70 1.19–2.42 .002
Shock at surgical intervention Yes/no 0.95 0.36 2.60 1.30–5.20 .007
Complete revascularization Yes/no 0.84 0.37 0.43 0.21–0.89 .023
CPB time Continuous (D ¼ 10 min) 0.08 0.03 1.08 1.02–1.15 .002
Culprit artery
Age Continuous (D ¼ 10 y) 0.55 0.18 1.73 1.22–2.54 .003
Shock at surgical intervention Yes/no 0.93 0.35 2.54 1.27–5.08 .009
Culprit revascularizationy Yes/no 0.75 0.34 0.47 0.24–0.93 .029
CPB time Continuous (D ¼ 10 min) 0.08 0.03 1.08 1.02–1.15 .002
b, Regression coefficient; RR, Relative risk; 95% CI, 95% confidence interval of relative risk; CPB, cardiopulmonary bypass. *Cox proportional hazards regression analysis with
manual backward elimination. yRevascularization of the infarct-related artery.A
C
Drevascularization and no revascularization of the culprit ar-
tery were independent predictors of poor long-term survival.
Anterior or posterior location of the VSR did not influence
late outcome.
DISCUSSION
In the prethrombolytic era, 1% to 2% of patients with
AMI had VSR. After the introduction of thrombolytic ther-
apy, there has been a 5- to 10-fold reduction in the incidence
of postinfarction VSR, and in the GUSTO-I trial of 41021
patients with ST-segment elevation infarction, 0.2% of
those treated with thrombolysis had VSR.1 The same reduc-
tion has been demonstrated for patients undergoing primary
PCI during AMI.2-4 In contrast, we found no reduction in the
number of patients admitted with VSR throughout the study
period, but thrombolysis or acute PCI was performed in only
24 of 102 patients. VSR remains a surgical challenge, with
significant morbidity and mortality. Most studies from the
last 2 decades report 30% to 60% early mortality (30-day
mortality or death during same hospital stay)13-15 or 30-
day mortality,1,6,16-21 although early mortality has been as
low as 23%22 and as high as 81%5 in recent reports. How-
ever, comparison between reports is unreliable because the
natural course of AMI might have changed, and the recruit-
ment of patients for surgical intervention differs signifi-
cantly. The present study showed a significant reduction in
30-day mortality, from 45% in the first half to 21% in the
second half of the study period. The 5- and 10-year cumula-
tive survival, 30-day mortality included, was 50% and 32%,
respectively. This is in accordance with other recent studies
that report 5-year cumulative survival in the range 40% to
45% and 10-year survival in the range of 25% to
40%.13,19,20,23,24 Five- and 10-year survival is usually
10% to 20% higher if patients who die within 30 days are
excluded from the analysis.14,21,25
After the introduction of thrombolytic therapy, the aver-
age time between AMI and VSR has been reported to
decrease from 5 to 7 days to close to 1 day.1,5,26-28 In
accordance with other recent reports,2,29 such a shift wasThe Journal of Thoracic and Cnot supported by our study. Time from AMI to VSR was
constant (median, 5 days) for the entire study period and
for the 24 patients undergoing thrombolysis or acute PCI.
In accordance with previous studies,17,21 we found that
time from AMI to VSR did not predict early or late outcome,
although one other study has reported that shorter time from
AMI to VSR increased the early mortality.19
Previously, surgical intervention was often delayed for
several weeks while waiting for stable hemodynamics and
for myocardial fibrosis to occur. This will certainly improve
outcome because the surgical procedure is easier and the
sickest patients die before surgical intervention. Currently,
the majority of surgeons follow a more aggressive approach,
with immediate start of IABP and urgent VSR repair, usually
within 24 hours after diagnosis. Accordingly, patients now
undergo operations closer in time to the AMI, when the
hemodynamic state is poorer and the myocardium is more
fragile for the repair. Time from diagnosis of VSR to the
operation decreased significantly during the study period,
but the shift to earlier surgical intervention did not increase
early or late mortality. This does not necessarily exclude
such a correlation but probably reflects the time window
for surgical intervention in our study. The patients under-
went operations a median of 2 days after the VSR diagnosis,
70% underwent operations within 3 days after VSR, and
only 7 patients underwent operations in the late phase
(>30 days from AMI). Accordingly, because the majority
of patients underwent operations within an early and narrow
time window after VSR, this parameter could not discrimi-
nate between survivors and nonsurvivors. Our results there-
fore do not exclude previous findings that surgical
intervention even closer in time to the occurrence of VSR
can increase the operative risk or that outcome is better
when surgical intervention is delayed for weeks or months.
Previous studies on the association between the timing of
surgical intervention and early mortality are conflicting. Al-
though shorter time from VSR to surgical intervention has
been reported to increase the operative risk,20,21 the majority
of studies show no association.13,19,23,30 This discrepancyardiovascular Surgery c Volume 137, Number 4 865
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versus late surgical intervention varies between these stud-
ies. Not surprisingly, early mortality is higher for patients
undergoing operations 1 to 2 days versus several weeks or
months after VSR, while it is difficult to detect differences
in outcome when comparing patients who undergo opera-
tions within the first days after VSR. None of these reports
could demonstrate any association between the timing of
surgical intervention and long-term survival.
Advanced age was not an independent predictor of 30-day
mortality in our study. This corresponds well with several
previous reports.13,17,19-21,30 Higher age was an independent
risk factor for poor long-term survival, which probably only
reflects that older persons have a shorter life expectancy.
Long CPB time was a moderate risk factor of 30-day mor-
tality and total mortality, with the strongest effect on early
outcome. Prolonged CPB was not a predictor of cumulative
mortality in 30-day survivors. This suggests that the en-
hanced total mortality was a result of many postoperative
deaths and that prolonged CPB had no persisting biologic ef-
fect. Even though CPB can provoke end-organ failure by
triggering cascade systems and inducing inflammation, the
adverse effect of prolonged CPB might be seriously con-
founded by underlying factors because CPB time can be
a surrogate for a complicated and time-consuming procedure
or for difficulties in weaning a severely damaged heart from
CPB. The VSR repair and CABG procedures themselves
probably did not contribute to the differences in CBP time
between survivors and nonsurvivors because there was no
significant difference in aortic crossclamp time.
Shock at surgical intervention was the strongest indepen-
dent risk factor of 30-day mortality (odds ratio, 4.8). This
corresponds well with other reports, in which shock has
been identified as an important determinant of early
death.14,15,17,19,30 We found that shock was also a predictor
of total mortality (relative risk, 2.6), which is in contrast to
several previous studies.8,14,19,21,30 However, shock was
not a predictor of cumulative mortality in 30-day survivors.
This suggests that the enhanced total mortality was a result
of many postoperative deaths and that shock had no persist-
ing biologic effect. The definition of shock varies widely in
a clinical setting, and different studies use divergent defini-
tions or have no definitions at all. We used a clear and strict
definition of preoperative shock at surgical intervention: hy-
poperfusion leading to acute renal failure manifested by oli-
guria/anuria or an acute increase in creatinine value to
greater than 200 mmol/L. Cardiogenic shock depends largely
on the amount of damaged myocardium; the degree of left
ventricular necrosis predicts shock in anterior VSR, and
the degree of right ventricular necrosis predicts shock in pos-
terior VSR.8,31 The AMI is usually biventricular in patients
with VSR, and especially right ventricular dysfunction has
been shown to be a strong predictor of early death.23 Heart
failure also depends on the amount of shunting, which is866 The Journal of Thoracic and Cardiovascular Suragain dependent on VSR size, on ventricular function, and
on systemic versus pulmonary vascular resistance. In accor-
dance with these findings, univariable analysis showed high
maximal ASAT values after AMI and large preoperative
shunt to be risk factors for 30-day mortality. Because these
variables were measured in only a subset of patients, they
could not be included in the regression analysis. The quality
of preoperative echocardiographic analysis was suboptimal
for a systematic quantification of myocardial function.
Therefore although the extent of myocardial damage and
preoperative shunt size were associated with poor early out-
come, we could not expose the exact underlying hemody-
namic mechanisms for development of shock.
The role of coronary revascularization during VSR repair
is controversial. It can be argued that revascularization of
transmurally infarcted myocardium is not logical, and be-
cause the culprit artery is often entrapped in the suture line
of the ventriculotomy, it can be impossible to bypass.7,32,33
Coronary angiographic analysis is time-consuming and po-
tentially dangerous in an unstable patient and can lead to
contrast-induced renal failure. However, we have not lost
any patients during coronary angiography, and this is also
the experience from several other studies.8,23,32,34 We avoid
contrast injection of the left ventricle to minimize the risk of
cardiotoxic reactions and renal failure. A majority of studies
have found no effect of concomitant CABG on early mortal-
ity14,16,18-22,34,35 or long-term survival,14,16,18,19,21 whereas
CABG has been reported to reduce midterm survival in
30-day survivors.20 Other studies support our findings that
revascularization is associated with improved early32 and
late22,32,34,35 survival, which indicates that concomitant
CABG can control the added risk of coronary artery disease.
We showed that complete global coronary revascularization
and revascularization of the culprit artery both resulted in
improved 30-day survival and long-term survival.
The frequency of 1-vessel versus multivessel disease dif-
fers between studies covering the same time period as ours,
with a proportion of 1-vessel disease varying from 20% to
40%13,15,22 up to 50% to 60%.6,19,29,31,34 The effect of re-
vascularization in a particular VSR cohort will depend on
the pattern of coronary disease because revascularization
will be more important in widespread coronary disease
than in patients with only 1-vessel disease of a culprit artery.
As many as 63% had 2- or 3-vessel disease, which explains
the importance of complete revascularization in our cohort.
Revascularization of the infarct-related artery itself was an
important predictor of improved outcome. If not beneficial
for the infarcted myocardium itself, revascularization of
the culprit artery might improve perfusion of the ischemic
border zone and control ventricular arrhythmias.
Even though complete coronary revascularization was as-
sociated with improved early and late survival, we have no
proof of a direct cause-effect relationship. The positive ef-
fect might be seriously confounded by the quality of thegery c April 2009
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tients with severely diseased and calcified coronary arteries.
Accordingly, patients with better coronary arteries can un-
dergo a more extensive coronary revascularization. In
most retrospective studies, CABG is performed when indi-
cated and technically possible. The extent of coronary revas-
cularization is therefore a surrogate for the degree of
coronary disease; patients with multivessel disease receive
more distal anastomoses than patients with 1-vessel disease.
No retrospective studies can, with certainty, validate the ef-
fect of CABG during VSR repair. One would need a large
prospective trial with a control group in which CABG to op-
erable arteries is deliberately omitted, and such a study will
probably never be performed.
Thirty-day mortality decreased significantly from 45% in
the first half to 21% in the second half of the study period. A
similar reduction in operative risk during the years 1980 to
1992 (n¼ 109) has been described by Cox and coworkers,17
whereas 3 other authors found no reduction in early mortal-
ity during the recent decades: Killen and associates13 (1970-
1994, n¼ 68), Labrousse and colleagues14 (1971-1991, n¼
85), and Mantovani and coworkers21 (1983-2002, n ¼ 50).
The reasons for our improved early results in recent years
are complex. Although time from AMI to VSR was constant
throughout the study period, the natural course of AMI
might have changed on introduction of thrombolysis and
acute PCI. There was a shift toward more immediate surgical
intervention in the second half of the study period, which
might20 or might not13,23,30 increase early mortality. Finally,
the surgical repair technique has changed, and surgical expe-
rience and patient care might have improved. Probably these
factors have stronger influence on operative risk than on
long-term survival, for which cardiac pathology and comor-
bidity are more important. Accordingly, long-term survival
was not influenced by year of surgical intervention. Twenty
surgeons participated in the study. Thirteen surgeons per-
formed less than 5 procedures, 4 surgeons performed 5 to
10 procedures, and 3 surgeons performed more than 10 pro-
cedures. Although surgeon was not a predictor of outcome, 5
of the most-frequent operating surgeons were residents in
the first half of the study period and more experienced con-
sultants during the last part. A learning curve effect can
therefore partly explain improvement of early outcome dur-
ing time. Naturally, observation time was shorter for patients
undergoing operations in more recent years, making the sta-
tistical analysis less sensitive in detecting potential differ-
ences in late outcome.
In conclusion, repair of postinfarction VSR is still associ-
ated with high operative risk, with our 30-day mortality be-
ing 21% for the last decade. The 5- and 10-year cumulative
survival was 50% and 32%, respectively. Shock at surgical
intervention and incomplete coronary revascularization
were strong and independent risk factors of 30-day mortality
and poor long-term survival. Anterior or posterior locationThe Journal of Thoracic and Cof the VSR did not influence outcome. We recommend im-
mediate coronary angiography and IABP support, followed
by urgent surgical repair, which should include complete
coronary revascularization.
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